Recombinant human interleukin 24 reverses Adriamycin resistance in a human breast cancer cell line-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recombinant human interleukin 24 reverses Adriamycin resistance in a human breast cancer cell line

Published:2014-10 Issue:5 Volume:66 Page:915-919
ISSN:1734-1140
Container-title:Pharmacological Reports
language:en
Short-container-title:Pharmacological Reports

Author:

Amirzada Muhammad Imran,Ma Xin,Gong Xiaohai,Chen Yun,Bashir Sajid,Jin Jian

Funder

China National Natural Science Foundation

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,General Medicine

Reference21 articles.

1. Cancer multidrug resistance (MDR) a major impediment to effective chemotherapy;Ullah;Asian Pacific J Cancer Prev,2008

2. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants;Juliano;Biochim Biophys Acta,1976

3. Reversal of multidrug resistance in human breast cancer cell line by Curcuma wenyujin and Chrysanthemum indicum;Yang;Phutomedicine,2011

4. Multidrug resistance: molecular mechanisms and clinical relevance;Ling;Cancer Chemother Pharmacol,1997

5. The power of the pump: mechanisms of action of P-glycoprotein (ABCB1);Ambudkar;Eur J Pharm Sci,2006

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of resistant MCF-7 breast cancer cells developed by repeated cycles of photodynamic therapy;Frontiers in Pharmacology;2022-09-16

2. Research Article Combination of endostatin and vinorelbine enhances control of breast cancer cells while endostatin ameliorates the toxicity of vinorelbine in normal cells;Genetics and Molecular Research;2020

3. Chemotherapy and Inflammatory Cytokine Signalling in Cancer Cells and the Tumour Microenvironment;Advances in Experimental Medicine and Biology;2019

4. The down-regulation of SLC7A11 enhances ROS induced P-gp over-expression and drug resistance in MCF-7 breast cancer cells;Scientific Reports;2017-06-19

5. ILs-3, 6 and 11 increase, but ILs-10 and 24 decrease stemness of human prostate cancer cells in vitro;Oncotarget;2015-10-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3